VEGFA and cardiovascular disorder: Administered in the form of recombinant protein or via naked or adenoviral vector-mediated gene transfer, the vascular endothelial growth factor A (VEGF-A; especially its primary isoform with 165 amino acids, VEGF-A165) has shown potential beneficial effects in cardiovascular diseases and wound healing and has received increasing attention6,7.